Oasmia to NGM Equity
Oasmia to NGM Equity
Oasmia Pharmaceutical is being listed on NGM Equity, Sweden on September 18th 2007. This provides private and institutional shareholders with a better place to trade in the company's shares.
Oasmia is now ready to move forward to provide financial institutions and large inves-tors with an interesting, long term investment opportunity.
- Our product portfolio within oncology is very strong, and we are in the near future approaching the veterinary market with a revolutionary cancer therapy for dogs.
The positive development means that Oasmia is becoming a more and more attractive investment opportunity and that the company will benefit from being listed on NGM Equity, says Julian Aleksov, CEO of Oasmia.
For more information and downloading of the Listing prospectus, please visit our website www.oasmia.com
The press release is available in PDF-format here.
